Optimal Antithrombotic Therapy in Ischemic Stroke Patients with Non-Valvular Atrial Fibrillation and Atherothrombosis

Stopped The trial was terminated at the planned interim analysis for futility on July 18, 2023.

Conditions

• Ischemic Stroke
• Atrial Fibrillation
• Atherothrombosis

Interventions

• DRUG: Oral Anticoagulant
• DRUG: Antiplatelet Drug

Sponsor

National Hospital Organization Osaka National Hospital

Collaborators

• [object Object]
• [object Object]